On the contrary, different genetic manipulations in mice, resulting in lower expression of either Bdnf or its TrkB receptor, cause hyperphagia and induce signs of metabolic syndrome including leptin and insulin resistance, dyslipidemia and hyperglycemia (Kernie et al., 2000; Rios et al., 2001). Here, BDNF is linked to metabolic syndrome.